Diseases and Symptoms,  First Aid and Emergency

Parkinson’s Disease – A New Risk Factor Discovered

A Parkinson’s disease is a neurodegenerative disorder that affects the central nervous system and causes several symptoms that significantly impact the quality of life of those affected. The causes of the disease have been researched for a long time, and the scientific community increasingly identifies the role of environmental and genetic factors. In recent years, several studies have addressed various risk factors, paying particular attention to pesticides and their effects.

During the research, numerous chemicals were analyzed, and it was found that certain pesticides, such as DDT, pose a particularly high risk. Additionally, genetic background plays a key role, as the presence of certain gene variants may increase the likelihood of developing the disease. Studies conducted among adult men concluded that environmental effects and genetic factors intertwined can increase the risk of Parkinson’s disease.

The relationship between pesticides and Parkinson’s disease

The increased risk of Parkinson’s disease is closely associated with the use of pesticides, particularly DDT. DDT is an organochlorine insecticide that was widely used before it was discovered to have toxic effects in the long term. Men who worked in agriculture and were exposed to chlorinated organic compounds were particularly likely to experience the onset of Parkinson’s disease symptoms.

In a study conducted by French researchers, men exposed to pesticides similar to DDT had three and a half times higher likelihood of developing the disease if they carried certain genetic variants. This relationship suggests that, alongside environmental factors, genetic predisposition also plays a significant role in the development of the disease.

Researchers emphasized that the effects of DDT and other pesticides may not only affect agricultural workers but also their environment, as these substances can persist in soil and water for long periods, potentially causing broader health issues.

Genetic factors and Parkinson’s disease

The role of genetic background in the development of Parkinson’s disease is increasingly coming into focus. Research indicates that certain genes, such as ABCB1, significantly impact the brain’s ability to remove toxic substances. The ABCB1 gene codes for a type of “pump protein” responsible for filtering out toxins.

Researchers found that individuals who carry two copies of the gene have a less effective pump function than those who carry only one. This genetic variation may explain how exposure to environmental toxic substances can lead to the development of Parkinson’s disease.

In genetic studies, the genomes of 101 men living with Parkinson’s disease and 234 healthy men were analyzed. The results clearly show that genetic factors and environmental effects together can increase the risk of the disease. Therefore, it is crucial for the scientific community to continue research to better understand the mechanisms of disease development, thus facilitating prevention and the development of treatment options.

The role of prevention

To prevent Parkinson’s disease, it is important to identify and reduce potential risk factors as early as possible. Limiting the use of pesticides, particularly DDT and similar substances, could be a step towards mitigating the risk of the disease. Public awareness of the effects of environmental toxic substances is also essential, as the primary means of prevention is a conscious lifestyle and the establishment of safe working conditions.

Based on scientific research results, the introduction of genetic screenings may also be useful for identifying high-risk individuals. Those suspected of having a genetic predisposition could be given the opportunity for early attention and preventive measures, thus reducing the risk of developing Parkinson’s disease.

In addition to prevention, early detection and treatment of the disease are also crucial. The scientific community is continuously working on developing new treatment methods and therapies to improve the quality of life for those living with Parkinson’s disease and to support them in overcoming everyday challenges.